TP53 and thymus lymphoma: Our previous work utilizing genetically engineered mice with in vivo short hairpin RNA (shRNA) targeting p53 demonstrated that temporarily reducing p53 expression in mice during fractionated low-dose total-body irradiation (TBI) reduced the risk of thymic lymphoma development (8).